From Prediction to Practice: A Task-Aware Evaluation Framework for Blood Glucose Forecasting

> Paper: From Prediction to Practice: A Task-Aware Evaluation Framework for Blood Glucose Forecasting > Authors: Alireza Namazi, Heman Shakeri > arXiv: 2605.00645 | 2026-04-30

The Trap of Small Average Error but Critical Failures

Imagine a glucose forecasting model with:

• An average error of 15 mg/dL — looks good
• But no warning before hypoglycemic events
• Or it suggests wrong insulin doses during hyperglycemia

The problem: traditional metrics (RMSE, MAE) cannot capture clinically critical failures.

Evaluation Blind Spots in Clinical Time-Series Forecasting

Limitations of standard evaluation metrics:

1. Deceptive averages

• Low mean error can mask dangerous failures
• In safety-critical settings, extreme errors matter more than average ones

2. Detachment from actual tasks

• Models are trained for specific clinical tasks
• But evaluation is generic (e.g., RMSE)
• It does not reflect real-world value in use

3. Ignoring risk asymmetry

• Hyperglycemia and hypoglycemia risks are asymmetric
• Hypoglycemia can be immediately life-threatening
• Standard metrics do not distinguish these

Two key downstream tasks in glucose forecasting: 1. Hypoglycemia early warning: alert the patient before danger occurs 2. Insulin dosing decision support: help the patient decide how much insulin to inject

The Task-Aware Evaluation Framework

The paper proposes evaluating models around the downstream tasks:

Task 1: Hypoglycemia Early Warning

Metrics:

• Event-level recall — of the hypoglycemic events that actually occur, how many were flagged in advance? Not "is the forecast close to ground truth," but "did it sound the alarm before danger"
• Warning time — how far in advance? 5 minutes vs. 30 minutes of lead time have completely different value
• False positive rate — too many false alarms cause alarm fatigue; patients may start ignoring alerts

Task 2: Insulin Dose Decision Support

Metrics:

• Dose safety — would the suggested dose cause hypoglycemia? Safety matters more than precision
• Dose effectiveness — does the suggested dose keep glucose in target range? Not forecast accuracy, but decision quality
• Clinical acceptability — does the suggestion conform to clinical guidelines? Would clinicians/patients accept it?

Validation on three real clinical cohorts:

• Verified on real-world data
• Spanning different patient populations
• Ensuring generalizability

Why Task-Aware Evaluation Matters

Traditional evaluation:

• "Model A has RMSE 12, Model B has 15"
• "So Model A is better"
• But Model A may fail completely at the critical moment

Task-aware evaluation:

• "Model A warned on 80% of hypoglycemic events, with an average 20-minute lead"
• "Model B warned on 90%, with an average 30-minute lead"
• "So Model B is better" — even with a higher RMSE

Clinical value:

• Clinicians care about "can the model help me make better decisions"
• Not "how good are its mathematical metrics"
• Task-aware evaluation bridges this gap

A Feynman-Style Judgment: Useful Measurement Must Reflect the Real Goal

Feynman said:

> "If you cannot measure what you truly care about, your measurement is meaningless."

In medical AI:

> "If you evaluate a glucose forecasting model with RMSE, you are measuring 'how far the forecast is from ground truth on average,' not 'whether it can save patients.' These are correlated but not identical. What truly matters is whether the model is useful in clinical practice."

The philosophy of task-aware evaluation: evaluation must align with the end goal.

• If the goal is warning → evaluate warning capability
• If the goal is decision support → evaluate decision quality
• Do not substitute a generic metric for task-specific evaluation

Takeaways

If you are evaluating a medical AI system, ask yourself:

1. "Do my evaluation metrics reflect the clinical outcomes I actually care about?" 2. "Does low average error mask critical safety failures?" 3. "Have I evaluated the model's value in real-world usage scenarios?" 4. "Do different downstream tasks require different evaluation methods?"

The core lesson: in medical AI, "prediction accuracy" is not "clinical usefulness."

A model can have very low RMSE yet fail at the critical moment — and in medicine, the critical moment is everything. Task-aware evaluation forces us to shift from asking "how accurate is the prediction" to "can the prediction save lives." In glucose forecasting, the best model is not the one that performs best on average, but the one that never stays silent when danger strikes.